These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 27420035)
21. The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease. Kuang M; Sheng G; Hu C; Lu S; Peng N; Zou Y Lipids Health Dis; 2022 Oct; 21(1):104. PubMed ID: 36266655 [TBL] [Abstract][Full Text] [Related]
22. The Impact of NAFLD and Waist Circumference Changes on Diabetes Development in Prediabetes Subjects. Lee J; Cho YK; Kang YM; Kim HS; Jung CH; Kim HK; Park JY; Lee WJ Sci Rep; 2019 Nov; 9(1):17258. PubMed ID: 31754157 [TBL] [Abstract][Full Text] [Related]
23. Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study. Song JU; Jang Y; Lim SY; Ryu S; Song WJ; Byrne CD; Sung KC PLoS One; 2019; 14(1):e0208736. PubMed ID: 30673698 [TBL] [Abstract][Full Text] [Related]
24. A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis. He X; Huang X; Qian Y; Sun T Front Endocrinol (Lausanne); 2023; 14():1188214. PubMed ID: 37484966 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study. Joo EJ; Chang Y; Yeom JS; Ryu S Hepatology; 2017 Mar; 65(3):828-835. PubMed ID: 28035771 [TBL] [Abstract][Full Text] [Related]
26. [Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents]. Clemente AP; Netto BD; de Carvalho-Ferreira JP; da Silveira Campos RM; de Piano Ganen A; Tock L; de Mello MT; Dâmaso AR Rev Paul Pediatr; 2016; 34(1):47-55. PubMed ID: 26830602 [TBL] [Abstract][Full Text] [Related]
27. Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-up. Xu C; Ma Z; Wang Y; Liu X; Tao L; Zheng D; Guo X; Yang X Liver Int; 2018 Dec; 38(12):2294-2300. PubMed ID: 30099825 [TBL] [Abstract][Full Text] [Related]
28. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. Pang Q; Zhang JY; Song SD; Qu K; Xu XS; Liu SS; Liu C World J Gastroenterol; 2015 Feb; 21(5):1650-62. PubMed ID: 25663786 [TBL] [Abstract][Full Text] [Related]
29. Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study. Niriella MA; Kasturiratna A; Beddage T; Ediriweera DS; De Silva ST; Perera KR; Subasinghe CE; Kodisinghe SK; Piyaratna TC; Rishikesawan V; Dassanayaka AS; De Silva AP; Pathmeswaran A; Wickramasinghe AR; Kato N; Janaka de Silva H PLoS One; 2019; 14(10):e0224474. PubMed ID: 31661524 [TBL] [Abstract][Full Text] [Related]
30. Association Between Fatty Liver Index and Risk of Breast Cancer: A Nationwide Population-Based Study. Park JH; Choi IS; Han KD; Park H; Kim KH; Kim JS Clin Breast Cancer; 2020 Aug; 20(4):e450-e457. PubMed ID: 32192863 [TBL] [Abstract][Full Text] [Related]
31. Association between weight-adjusted waist index and non-alcoholic fatty liver disease: a population-based study. Yu C; He S; Kuang M; Wang C; Huang X; Sheng G; Zou Y BMC Endocr Disord; 2024 Feb; 24(1):22. PubMed ID: 38369482 [TBL] [Abstract][Full Text] [Related]
32. Long working hours and increased risks of lean non-alcoholic fatty liver disease among Korean men and women. Lim GY; Chang Y; Kim I; Ryu S; Kwon R; Song J Sci Rep; 2023 Jul; 13(1):12230. PubMed ID: 37507409 [TBL] [Abstract][Full Text] [Related]
33. Nonalcoholic Fatty Liver Disease Incidence and Remission and Their Predictors During 7 Years of Follow-up Among Finns. Korpimäki S; Rovio SP; Juonala M; Hutri-Kähönen N; Lehtimäki T; Laitinen TP; Tossavainen P; Jokinen E; Loo BM; Männistö S; Tammelin T; Haarala A; Aatola H; Komar G; Viikari J; Raitakari O; Kähönen M; Pahkala K J Clin Endocrinol Metab; 2023 Dec; 109(1):e291-e305. PubMed ID: 37463486 [TBL] [Abstract][Full Text] [Related]
34. Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease. Chang Y; Jung HS; Yun KE; Cho J; Ahn J; Chung EC; Shin H; Ryu S Obesity (Silver Spring); 2016 Sep; 24(9):1996-2003. PubMed ID: 27474900 [TBL] [Abstract][Full Text] [Related]
35. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults. Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650 [TBL] [Abstract][Full Text] [Related]
36. The haemoglobin glycation index is associated with nonalcoholic fatty liver disease in healthy subjects. Yoo JH; Kang YM; Cho YK; Lee J; Jung CH; Park JY; Ryu OH; Kim HK; Lee WJ Clin Endocrinol (Oxf); 2019 Aug; 91(2):271-277. PubMed ID: 31046138 [TBL] [Abstract][Full Text] [Related]
37. [Relationship between waist circumference trajectory and new-onset non alcoholic fatty liver disease in the non-obese population]. Wang S; Zhang J; Jiang XZ; Tong B; Wang Q; Zhang WH; Yang YY; Xia JX; Wu SL Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jun; 41(6):824-828. PubMed ID: 32564543 [No Abstract] [Full Text] [Related]
38. Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study. Yadav D; Choi E; Ahn SV; Koh SB; Sung KC; Kim JY; Huh JH Medicine (Baltimore); 2016 Aug; 95(31):e4447. PubMed ID: 27495073 [TBL] [Abstract][Full Text] [Related]
39. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period. Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491 [TBL] [Abstract][Full Text] [Related]
40. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y. Li XD; Qiu BH; Su FC; Sun SX Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]